Precision Radiation Therapy – China Cancer Help

CLINICAL APPLICATION & CRITERIA

Precision Radiation Therapy in China

Radiotherapy uses high-energy radiation to damage cancer cell DNA and prevent tumor growth, serving as a curative, adjuvant, neoadjuvant, or palliative modality across more than half of all cancer patients. Modern precision radiotherapy — including intensity-modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), stereotactic body radiation therapy (SBRT), and volumetric modulated arc therapy (VMAT) — sculpts radiation dose around the tumor while sparing healthy tissue. When integrated with chemotherapy, immunotherapy, or surgery, radiotherapy significantly improves local control and survival outcomes for a broad range of cancers.

CLINICAL INDICATIONS

Key Cancers Treated with Precision Radiation Therapy

Sub-millimeter image-guided radiotherapy, robotic CyberKnife radiosurgery, and helical TomoTherapy delivered by specialized radiation physicists:

Nasopharyngeal Cancer

Definitive helical TomoTherapy and 4D-VMAT delivering dose conformality for nasopharyngeal carcinoma while sparing parotids and optic nerves.

Learn More

Lung Cancer

Ablative short-course SBRT delivering high tumoricidal doses in 3–5 fractions for medically inoperable early-stage lung tumors and oligometastases.

Learn More

Breast Cancer

Surface-guided deep-inspiration breath-hold (DIBH) radiotherapy virtually eliminating heart and left anterior descending coronary radiation exposure.

Learn More

WHY CHOOSE US

Why Choose China for Precision Radiation Therapy

A specialized cross-border continuum connecting international patients directly with China's leading radiation oncology departments.

China has built one of the world’s largest radiotherapy networks, with linear accelerators installed across major tertiary hospitals and rapidly expanding into regional centers. Indigenous manufacturers such as United Imaging and Shinva produce advanced LINACs, CT simulators, and treatment planning systems at competitive prices, while AI-driven auto-contouring platforms can reduce planning time from days to hours. Chinese radiation oncologists have accumulated world-leading clinical experience in nasopharyngeal carcinoma, esophageal cancer, and liver cancer — tumor types with particularly high incidence in China.

Treatment costs per fraction are substantially lower than in the US or Europe, and national insurance coverage continues to expand. International patients receive treatment at Grade 3A hospitals equipped with Varian, Elekta, and domestic latest-generation systems, supported by bilingual coordinators who manage scheduling, interpretation, and follow-up imaging, ensuring that precision radiotherapy is both accessible and seamlessly coordinated.

HOW IT WORKS

4 Steps to Treatment in China

A simple, step-by-step process from initial record review to your arrival and treatment in China.

01. Submit Records Online

Upload existing pathology reports, biomarker NGS profiles, and imaging scans through our secure clinical intake portal.

02. Pre-Screen & Doctor Match

Clinical eligibility and contraindication screening, matching your specific case with China's foremost oncology chiefs.

03. Doctor Consultation

One-on-one remote video consultation or written multidisciplinary assessment to confirm treatment protocol before travel.

04. Travel to China & Care

Expedited medical visa support, priority hospital admission, dedicated bilingual bedside escorts, and continuum follow-up.

PATIENT FAQS

Frequently Asked Questions

Key clinical, financial, and logistical insights for international patients considering care in China.

01. What technologies are used to ensure sub-millimeter radiation precision?

Centers utilize 4D-CT simulation, on-board cone-beam CT (CBCT), optical surface tracking, and AI-assisted real-time image guidance, ensuring radiation beams strictly conform to tumor boundaries despite respiratory motion.

02. Can SBRT replace surgery for early-stage lung cancer or liver cancer?

For patients who are medically inoperable or prefer non-invasive treatment, SBRT achieves local control rates exceeding 90% in early-stage NSCLC and solitary hepatocellular carcinoma, comparable to surgical resection.

03. How does TomoTherapy benefit patients with multiple metastases?

Helical TomoTherapy can treat multiple discontinuous lesions simultaneously across the brain, spine, or visceral organs in a single seamless session, avoiding field-matching junction issues.

04. What is the typical timeline for radiotherapy treatment in China?

Following simulation and AI auto-contouring, treatment typically commences within 3 to 5 business days. SBRT courses require only 1 to 2 weeks, while definitive fractionated radiotherapy ranges from 5 to 7 weeks.

CONFIDENTIAL CASE EVALUATION

Start with a Confidential Clinical Case Review

Submit your basic case details below for an initial eligibility review. Our medical team coordinates directly with chief oncologists at top Chinese cancer centers, returning a preliminary assessment and roadmap within 24–48 hours.

✓ Free initial triage • ✓ Direct specialist coordination • ✓ 100% Confidential